Copyright
©The Author(s) 2000.
World J Gastroenterol. Oct 15, 2000; 6(5): 633-635
Published online Oct 15, 2000. doi: 10.3748/wjg.v6.i5.633
Published online Oct 15, 2000. doi: 10.3748/wjg.v6.i5.633
CT grading | Treatment |
Grade A-C | Octreotide 0.1 mg q8h (H) × 5-7 d |
Bulpleurum Peony Cheng Qi decoction bid × 5-7 d | |
Grade D-E | Octreotide 0.1 mg/25% glucose IV |
0.5 mg/5% glucose in saline 1000 mL/24 h | |
thereafter 0.6 mg/5% glucose in saline 1000 mL/24 h × 5-7 d or more | |
or Stilamin 6 mg/5% glucose in saline 1000 mL/24 h × 5-7 d | |
Bulpleurum Peony Cheng Qi decoction 150 mL bid × 5-7 d | |
Plasma 400 mL-600 mL stat, 200 mL on 2nd and 3rd day each | |
Human serum albumin 10-20 g/d | |
Low molecular weight dextran (-40) + Dan Shen liquid 16-20 mL/glucose water | |
250 mL × 1-2 d, thereafter Dan Shen liquid in glucose in saline × 3-5 d | |
Ciprofloxacin 0.2 g bid + Metronidazole 100 mL bid × 4 weeks | |
or Imipenum 0.5 g q8h × 4 weeks | |
Compound aminoacids 500-750 mL qd, Intralipid 10% 500 mL qd | |
Fasting for food but not the herbal medicine | |
Omeprazole 40 mg IV gtt. qd × 7 d, | |
and then 20 mg per oral qd × 2-3 weeks | |
No atropine or gastric decompression | |
Calcium, potassium salts supplement with occasional magnesium salt |
- Citation: Wu XN. Treatment revisited and factors affecting prognosis of severe acute pancreatitis. World J Gastroenterol 2000; 6(5): 633-635
- URL: https://www.wjgnet.com/1007-9327/full/v6/i5/633.htm
- DOI: https://dx.doi.org/10.3748/wjg.v6.i5.633